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Summary
Objective: To assess differences in magnetic resonance imaging (MRI)-based compositional (T2) and morphometric (volume and thickness)
parameters of the tibio-femoral joint cartilage in subjects with and without osteoarthritis (OA) and compare these with clinical assessment tools
during a 1-year follow-up.
Method: Three Tesla MRI of the knee joint was performed in eight female patients (body mass index [BMI]> 30) with early OA and 10 age-
matched female controls (BMI< 30) at baseline (BL) and after 3, 6 and 12 months. Cartilage T2 maps, volume and average thickness were
calculated in ﬁve compartments (medial/lateral femoral condyle, medial/lateral tibia and trochlea). These data were correlated with changes in
clinical parameters and joint space width determined in standardized knee radiographs using a mixed random effects model.
Results: At BL, T2 was signiﬁcantly higher (P< 0.05) across the cartilage in patients (45.68 5.17 ms) compared to controls
(41.75 4.33 ms). Patients had signiﬁcantly (P< 0.05) less cartilage volume and less average cartilage thickness in the tibia than controls
(2.10 0.53 cm3 vs 2.91 0.49 cm3 and 1.59 0.24 mm vs 1.90 0.29 mm, respectively). A signiﬁcant change in clinical parameters of
OA, cartilage T2 values or a decrease of volume and average thickness could not be demonstrated within both groups.
Conclusion: Signiﬁcant differences between the groups indicate that both T2 and morphometric parameters may be useful in quantifying early
OA related changes. In a 12-month follow-up, however, no signiﬁcant alterations of the studied parameters were found, which may be due to
the length of the observation interval.
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SocietyIntroduction
Osteoarthritis (OA) is the most common joint disease. It is
anticipated that by the year 2020, an estimated 59.4 million
people in the US (18% of the population) will be affected1.
Since it is a leading cause of long-term chronic disability it
is associated with substantial cost to the individual and
the society2. Therefore, considerable effort has been taken
to develop structure modifying drugs, which not only relieve
inﬂammation and painful symptoms of OA but also prevent
disease progression3,4. This implies the need for the devel-
opment of optimized biomarkers to assess the status of OA
in an individual patient.
During the course of the disease the normal balance of
degradation and synthesis of articular cartilage chondro-
cytes, extracellular matrix and subchondral bone is destabi-
lized. In consequence, the matrix proteoglycans are lost
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Received 12 December 2006; revision accepted 9 April 2007.122and water content is increased. Later structural changes
like cleavage of collagen occurs. In a ﬁnal stage, macromor-
phological changes of the cartilage lead to progressive car-
tilage loss in affected joints5.
The most widely used method which is currently ac-
cepted to monitor progression of knee OA is the sequential
assessment of the joint space width (JSW) with radio-
graphs. However, radiographs are a relatively insensitive
method and large studies of 18e24 months duration may
be required to demonstrate changes6. Currently, magnetic
resonance imaging (MRI) is the best imaging technique to
qualitatively and quantitatively assesses articular cartilage
in all three dimensions. With cartilage-dedicated sequences
MRI has the ability to quantify cartilage morphology: loss of
volume and average thickness could be demonstrated dur-
ing the progress of OA7e12. The estimation of cartilage T2
relaxation times yields information concerning cartilage
biochemical composition: it is sensitive to a wide range of
water interactions in tissue including macromolecular con-
centration13e16, structure of the macromolecules17, and
bulk organization of the extracellular matrix18. In particular,
it therefore also depends on the content, orientation and
anisotropy of collagen19,20. Consequently, ﬁndings from5
1226 R. Stahl et al.: Knee OA: cartilage T2 and volume changeseveral studies indicate higher T2 relaxation times in carti-
lage of OA patients compared to healthy controls21,22 and
there is an evidence that they are correlated with the sever-
ity of the disease23,24.
Fig. 1. Illustration of the automatic partitioning of the cartilage of the
femoral condyles into weight- and non-weight-bearing regions. This
algorithm consisted of three steps: ﬁrst, the longitudinal axis of the
femur was computed. Second, the intersection angle between the
longitudinal femur axis and the angle of the normal vector to each
point of the Bezier splines generated during the segmentation pro-
cess was computed. Third, each point of the Bezier spline was as-
signed to a region: points belonging to the weight-bearing region
were those with an absolute value of the intersection angle of
30 (as computed in the previous step); the remaining points be-
long to the non-weight-bearing region. The long arrows with a solid
line are samples of normal vectors belonging to points within the
weight-bearing area (solid bordered parts of the segmented carti-
lage); the short arrows with dashed lines are samples of normal
vectors belonging to points of the non-weight-bearing areas
(dashed bordered parts of the segmented cartilage). The thick ver-
tical line parallels the longitudinal femur axis. The thin oblique lines
delineate the border between weight- and non-weight-bearing
areas in this section.Only a few studies performed follow-up examinations of
these MRI-derived parameters and if so, then the observa-
tion period was 1e4.5 years7e12,21. To our knowledge, the
variation of both T2 relaxation times and cartilage morpho-
metric parameters in knee cartilage during a 12-month
follow-up have not been speciﬁcally assessed. Thus, the
aims of this study were (1) to prospectively examine
changes in T2 relaxation times of knee cartilage during
a 1-year follow-up in a cohort of patients with early OA
and normal age-matched controls, (2) to compare these
changes with OA progression monitored by cartilage vol-
ume and thickness as well as radiographically determined
JSW and (3) to correlate these ﬁndings with validated clin-
ical assessment tools for OA.
Material and methods
PATIENTS AND CLINICAL ASSESSMENT
Eight female patients with OA (55.7 7.3 years) and 10 fe-
male age-matched controls (57.6 6.2 years) were recruited
for the study. Inclusion criteria for all subjects were age 40
years; good health by medical history, physical exam, and
clinical laboratories as well as no contra-indications for the
use of MRI. Additional inclusion criteria for the patients
were radiographic signs of OA (grade 2e3 based on the
KellgreneLawrence (KL) score25), clinical symptoms of knee
OA and a body mass index (BMI) 30. Patients with inﬂam-
matory arthritis were excluded and also those with knee
OA secondary to other causes (acute or chronic infection,
metabolic abnormalities, previous surgery or history of
Table I
Subject characteristics at BL. Age, weight and BMI values are re-
ported as means SD. Intergroup comparison was performed
with 1)t test and 2)Fisher’s exact test
Patients Controls P-values
N 8 10
Age [years] 55.7 7.3 57.6 6.2 0.5741)
Weight [kg] 92.1 10.2 58.2 6.2 <0.00011)
BMI 34.4 4.9 23.2 2.1 <0.00011)
KellgreneLawrence grade [n]
Grade 0 0 10 <0.00012)
Grade 2 4 0
Grade 3 4 0Table II
Subject characteristics in clinical pain assessment/quality of life-scores and JSW at BL and their rate of change during the 12-month follow-up.
SE: standard error of the mean. Intergroup comparison of the absolute values at BL1) was conducted with a t test, comparison of the slope2)
was performed with mixed model analysis after adjusting for age, height, and weight. P-values in bold indicate significant group differences
BL (meanSD) Change from BL (meanSE)
Patients Controls P-values1) Patients Controls P-values2)
Pain/quality of life-scores
Subject’s assessment
of arthritis pain (11-PT NRS)
1.9 2.0 0.3 0.7 0.054 1.45 1.05 0.39 0.93 0.45
Subject’s assessment
of arthritis pain (VAS)
14.1 14.8 3.3 4.3 0.042 11.14 9.24 3.24 8.11 0.52
SF-36 physical component scale 61.7 5.8 59.8 8.3 0.612 1.29 2.71 1.89 2.31 0.38
WOMAC OA index
Pain 4.4 3.5 0.5 1.1 0.004 2.15 1.71 0.54 1.49 0.48
Stiffness 2.3 1.7 0.3 0.7 0.004 0.43 0.68 0.00 0.59 0.64
Function 14.7 16.7 1.8 3.8 0.030 8.12 6.22 1.33 5.41 0.42
Total 21.4 21.4 2.6 5.2 0.016 10.73 8.43 1.87 7.33 0.43
Minimal JSW [mm] 3.01 1.02 3.06 0.95 0.068 0.36 0.75 0.07 0.29 0.29
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6intraarticular fracture). Controls had no clinical and radiolog-
ical (KL score¼ 0) evidence of knee OA and a BMI< 30.
Written informed consent was obtained from all patients after
the nature of the examinations had been fully explained. All
exams were performed in accordance with the rules and
regulations from the local Human Research Committee.
All subjects were evaluated at baseline (BL) and after 3,
6, and 12 months (FU3, FU6 and FU12, respectively). At
these time points several clinical scores and outcome ques-
tionnaires were obtained.
A standardized questionnaire (Western Ontario and
McMaster Universities Pain, Stiffness, and Physical Func-
tion scales, WOMAC) for measuring the degree of pain,
functional impairment and stiffness in all subjects through
a 5-point scale (none, slight, moderate, severe and
extreme) was used26. The subjects also completed the
Physical Health part of the Short Form General Health Sur-
vey (SF-36), which measures the health-related quality of
life. The SF-36 is a validated and widely used instrument
that allows quantiﬁcation of limitation of health quality in
eight domains: physical activity, role activity due to physical
problems, role activity due to emotional problems, vitality,
general mental health, social activity, bodily pain, and gen-
eral health. The responses to the Physical Health part of
these questions comprise a total of 21 items27. The subjects
assessed the severity of arthritis pain in their signal knee at
the time of the visit in two ways: ﬁrst by using an 11-point
numerical rating scale (11-PT NRS) which consists of an
11-point Likert scale with zero as ‘‘no pain’’ and 10 as
‘‘worst possible pain’’28. In addition pain was assessed by
using a 100-mm visual analog scale (VAS) between 0 (no
pain) and 100 (most severe pain).
IMAGING
Standing anteroposterior radiographs of the knee were
obtained in all subjects at BL to determine the Kellgrene
Lawrence score. Two additional radiographs were per-
formed on the signal knee at BL and FU3 to determine
the width of the femoro-tibial joint space (JSW). These ra-
diographs were taken from a posteroanterior position using
a SynaFlex frame (Synarc Inc.) to position the subject’s
feet reproducibly in a 10 external rotation and ﬁx the de-
gree of ﬂexion of both the tibia and femur. One view was
taken with the angle of the X-ray beam set to 10 (ﬁxed
Fig. 2. Color-coded T2 maps overlaid on SPGR images from the
lateral femoro-tibial compartment. Left: a healthy volunteer; right:
patient with early OA. In the healthy control, the T2 values were
3 4 . 2 1  1 1 . 0 9 ms i n t h e l a t e r a l f emu r c o n d y l e a n d
32.12 12.25 ms in the lateral tibia. In the patient, the T2 values
were 52.55  15.33 ms in the la teral femur condy le and
40.96 19.37 ms in the lateral tibia. The blank areas (arrows) in the
color-map were excluded manually during the post-processing
because of partial volume artifacts due to ﬂuid.
1228 R. Stahl et al.: Knee OA: cartilage T2 and volume changeview); the second view was taken by adjusting the angle of
the X-ray beam based upon ﬂuoroscopy to provide optimal
horizontal alignment of the medial tibial plateau (anterior
and posterior margins of the medial tibial plateau within
1.5 mm of each other, Modiﬁed Lyon-Schuss29,30).
MRI of the knee joint of the signal knee was performed on
a 3.0 T system (Signa, GE Medical systems, Waukesha,
WI, USA) using a dedicated knee coil, speciﬁcally devel-
oped for this study (Clinical MR Solutions, Brookﬁeld, WI,
USA) at BL and FU3e12. The MRI protocol included two
pulse sequences used for cartilage volume quantiﬁcation
and T2-mapping. The ﬁrst was a sagittal T1-weighted 3D
high-spatial-resolution volumetric fat-suppressed spoiled
gradient-echo (SPGR) sequence dedicated to cartilage im-
aging. Imaging parameters were as follows: repetition time
(TR)/echo time (TE) 20/7.5 ms, ﬂip angle of 12, number
of excitations 0.75 and acquisition time of 7 min 37 s. A total
Fig. 3. T2 relaxation times in the cartilage of the lateral compartment
(a), the femur (b) and the whole tibio-femoral joint (c). OA patients
present with signiﬁcantly higher values than the controls. The T2 re-
laxation times showed a trend for decrease over time in both subject
groups. However, this was not statistically signiﬁcant (P> 0.05).of 76 sections were acquired with a ﬁeld of view (FOV) of
15 cm (matrix 512 512) with an in-plane spatial resolution
of 0.293 0.293 mm2 and a slice thickness of 1.5 mm.
The second sequence used for T2 mapping was a sagittal
2D dual-echo fast spin echo (FSE) sequence for measuring
T2 relaxation time with TR/TE1/TE2 3600/8.5/34.1 ms,
echo train length of 6, matrix of 256 256, in-plane resolu-
tion of 0.625 0.625 mm2, FOV of 16 cm, one signal ac-
quired, acquisition time of 15 min 51 s and slice thickness
of 3 mm.
IMAGE ANALYSIS
All images were transferred to a Sun Workstation (Sun
Microsystems, Mountain View, CA, USA), and cartilage
segmentation was performed using in-house software31 de-
veloped with Matlab (Mathworks, Natick, MA, USA). Based
on the sagittal SPGR images, articular cartilage was seg-
mented using a semi-automatic technique based on Bezier
splines and edge detection, and was deﬁned in ﬁve distinct
regions: medial and lateral tibia, trochlea, medial and lateral
femur. Subsequently, the medial and lateral femoral
condyles were partitioned into weight-bearing and non-
weight-bearing portions: weight-bearing portions of the car-
tilage were deﬁned as those contiguous sections in which
the normal vectors to the splines exhibited a maximal devi-
ation of 30 from the longitudinal axis of the femur as dem-
onstrated in Fig. 1. The anterior and posterior sections of
the segmented cartilage of the femoral condyles were sum-
marized as non-weight-bearing portions.
The above-mentioned regions were combined to larger
units: medial and lateral femoral condyles and trochlea
were summarized as ‘‘femur’’; lateral (medial) tibial plateau
and lateral (medial) femoral condyle as ‘‘lateral (medial) com-
partment’’; lateral and medial tibial plateau as ‘‘tibia’’ and the
whole segmented cartilage of the tibio-femoral joint as ‘‘all’’.
Following segmentation, cartilage was transformed into
a 3D binary mask with isotropic voxels by using shape-
based interpolation with distance ﬁelds. Finally, the carti-
lage thickness was determined by calculating the minimum
Euclidean distance from each point on the articular surface
to the boneecartilage interface. The average thickness was
calculated for each slice and then averaged for all the sli-
ces. The cartilage volume was determined by multiplying
the total number of voxels encompassing the cartilage by
the actual volume of each voxel.
Studies have shown that variations in joint size havea larger
effect on cartilage volume than on cartilage thickness32.
Therefore, cartilage volume was normalized by dividing it by
the maximal epicondylar distance to minimize variation due
to joint size.
The dual-echo FSE images were used to generate sagittal
T2 maps, using custom software (IDL, Research Systems,
Boulder, CO, USA) and assuming mono-exponential signal
decaywith TE. These T2mapswere automatically registered
to the SPGR images with a rigid-body registration technique
to reduce effects of knee movement between the high-
resolution scan and the dual-echo scan.
Cartilage segmentations were then resampled and super-
imposed on the T2 maps to deﬁne the regions of interest for
T2 assessment as previously described21. The cartilage
compartments were deﬁned as the medial and lateral tibial,
trochlea as well as medial and lateral femoral weight-
bearing/non-weight-bearing compartments. Areas of partial
volume effects due to ﬂuid were manually excluded from the
T2 maps.
1229Osteoarthritis and Cartilage Vol. 15, No. 11Table IV
Cartilage volume [cm3] and its change over the 1-year follow-up. Intergroup comparison of the absolute values1) and of the slope2) was per-
formed with mixed model analysis after adjusting for age, height, weight and time point of examination. P-values in bold indicate significant
group differences. Lateral compartment3) consists of lateral femur condyle and lateral tibia plateau. Medial compartment4) consists of medial
femur condyle and medial tibia plateau
BL (meanSD) 12 Months (meanSD) Change from BL (mean SE)
Patients Controls Patients Controls P-values1) Patients Controls P-values2)
Femur (total) 8.98 2.05 8.13 1.62 8.91 1.48 8.17 1.58 0.489 0.04 0.26 0.03 0.22 0.834
Lateral condyle (weight-bearing) 1.07 1.25 1.39 0.38 1.53 0.74 0.88 0.88 0.126 0.27 0.38 0.52 0.31 0.117
Lateral condyle (non-weight-bearing) 2.55 1.07 1.97 1.27 2.37 1.08 2.12 0.62 0.473 0.18 0.33 0.16 0.27 0.434
Medial condyle (weight-bearing) 0.65 0.85 0.73 0.30 0.47 0.90 0.74 0.28 0.358 0.23 0.21 0.01 0.17 0.371
Medial condyle (non-weight-bearing) 1.90 0.54 1.50 0.52 1.72 0.45 1.47 0.42 0.454 0.02 0.13 0.07 0.11 0.749
Trochlea 2.06 0.55 2.11 0.51 2.15 0.42 2.19 0.45 0.869 0.02 0.13 0.07 0.11 0.746
Tibia (total) 2.10 0.53 2.91 0.49 2.41 0.92 2.94 0.49 0.001 0.44 0.14 0.01 0.11 0.020
Lateral plateau 1.24 0.49 1.75 0.35 1.38 0.73 1.76 0.35 0.003 0.23 0.08 0.00 0.07 0.030
Medial plateau 0.86 0.25 1.16 0.28 1.04 0.32 1.19 0.26 0.008 0.18 0.14 0.01 0.11 0.336
Lateral compartment3) 5.44 2.14 5.45 0.99 5.49 2.24 5.44 1.48 0.862 0.11 0.20 0.02 0.17 0.760
Medial compartment4) 3.57 0.73 3.48 1.10 3.68 0.93 3.48 0.96 0.116 0.26 0.23 0.06 0.19 0.305
All 11.07 2.24 11.04 1.95 11.32 2.29 11.11 1.99 0.514 0.40 0.34 0.04 0.28 0.421The segmentation and analysis were performed by a sin-
gle observer (RS). The overall long-term reproducibility was
evaluated between BL and FU3 since only minimal changes
were expected during this period.
Minimal JSW of the medial tibio-femoral compartment
was measured by an experienced observer using digitized
image analysis software (Holy’s software-beta19, Univer-
sity Claude Bernard (UCLB), Lyon, France) permitting the
contours of the joint space to be detected automatically
with the help of an edge-based algorithm. Measurements
were made automatically in a medial area of the compart-
ment, the external limit of which was determined by the ob-
server, who took care to exclude marginal osteophytes. The
computer then measured the minimum interbone distance
in each medial area.
STATISTICAL ANALYSIS
All the data analysis was performed with the statistical
analysis system, SAS V9.1 (SAS Institute Inc., Cary, NC,
USA). The study is a caseecontrol cross-sectional cohort
with prospective clinical outcome follow-up. Mean and stan-
dard deviation (SD) by visit and groups were calculated for
all numerical variables, such as the imaging measurements
(cartilage T2, thickness, and volume) and the clinical out-
come variables (WOMAC, SF-36 Physical health part,
VAS, 11-PT NRS, and JSW). WOMAC was log-transformed
to improve its distribution. Fisher’s exact probability and
t test were used to compare the signiﬁcance of individual
characteristic variables between two groups at BL, respec-
tively, for categorical variables and numerical variables. The
annual change of the measurement and outcome variables
over time was evaluated with mixed effects models, using
randomized intercepts by individuals and adjusting for ﬁxed
covariates of age, weight and height. Furthermore, correla-
tion and partial correlation with visit time were analyzed
between the measurement variables by compartments
and the subject characteristics or outcome variables.
Results
PATIENT CHARACTERISTICS
Given the subject inclusion criteria, age was not different
between the groups whereas OA patients had signiﬁcantlyhigher (P< 0.05) weight, BMI and KL score. Table I shows
the BL characteristics of all subjects.
CLINICAL PARAMETERS OF OA AND MINIMAL JSW
OA patients had signiﬁcantly higher (P< 0.05) values in
the WOMAC total score as well as in the subgroups for
pain, stiffness and function.OApatients reported signiﬁcantly
more (P< 0.05) arthritis pain compared to controls when as-
sessed with the visual analog scale (VAS). This value was
also higher when using the 11-PT NRS; however, not statis-
tically signiﬁcant at the 5% level. The SF-36 physical scores
did not differ between the groups. None of the above quoted
scores changed signiﬁcantly during the follow-up within the
groups as shown in Table II.
The minimal JSW obtained with modiﬁed Lyon-Schuss
technique29,30 at BL was slightly, but not signiﬁcantly lower
in OA patients compared to that of the controls. The amount
of change in JSW though mildly higher in OA patients was
not signiﬁcantly different between both groups (Table II).
PRECISION OF THE MRI MEASUREMENTS
The coefﬁcient of variation percentage value (CV%) for
the T2 relaxation time amounted to 1.6% when determined
with a commercially available phantom (Diagnostic Sonar,
Livingston, UK; with a known T2 relaxation time of 48 ms,
thus close to those of articular cartilage).
The root mean square CV% values for the intra-observer,
inter-scan setting considering the overall tibio-femoral carti-
lage in vivo were 3.01, 4.95 and 3.67 for T2 relaxation time,
cartilage volume and average cartilage thickness, respec-
tively. These results are similar to previous published
data33,34.
T2 RELAXATION TIME
In the mixed effect model, OA patients exhibited signiﬁ-
cantly higher (P< 0.05) T2 relaxation times in the femur,
lateral compartment and whole tibio-femoral cartilage com-
pared to controls (Table III; Figs. 2 and 3). The T2 relaxation
times did not show signiﬁcant changes over time in both
subject groups. However, there was a trend for decrease
in all compartments (Table III).
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Applying the mixed effect model, OA patients had signif-
icantly lower (P< 0.05) cartilage volume (Table IV and
Fig. 4) and average cartilage thickness (Table V and
Fig. 5) in both tibial plateaus compared to controls. OA pa-
tients exhibited a signiﬁcant increase (P< 0.05) of the
mean cartilage volume in the lateral tibia plateau as well
as in the whole tibia (Table IV; Figs. 4 and 6). In both sub-
ject groups, no signiﬁcant changes in average cartilage
thickness could be observed over time.
CORRELATION BETWEEN MRI-DERIVED PARAMETERS
T2 relaxation times showed strong positive correlation
with cartilage volume and average cartilage thickness at
Fig. 4. Cartilage volume in the lateral (a), medial (b) and whole tibial
(c) compartments. OA patients had signiﬁcantly lower values than
the controls. OA patients exhibited a signiﬁcant increase
(P< 0.05) of the mean cartilage volume in the lateral tibia plateau
as well as in the whole tibia over time.BL in OA patients in the non-weight-bearing areas of the
medial femur condyles (volume: r¼ 0.88, P¼ 0.004; aver-
age thickness: r¼ 0.85, P¼ 0.016), in the femur (volume:
r¼ 0.89, P¼ 0.008; average thickness: r¼ 0.89, P¼
0.007) as well as in the whole cartilage (volume: r¼ 0.92,
P¼ 0.004; average thickness: r¼ 0.92, P¼ 0.003). After
12-month follow-up, these correlations decreased notice-
ably. In the control group, no signiﬁcant correlations could
be demonstrated between T2 relaxation time and cartilage
volume or average cartilage thickness.
CORRELATION BETWEEN MRI-DERIVED PARAMETERS
AND CLINICAL PARAMETERS OF OA/MINIMAL JSW
Evaluation of the clinical course in all subjects demon-
strated no signiﬁcant correlation between changes in
cartilage T2 relaxation times and changes in clinical param-
eters as well as changes in JSW.
Changes in cartilage volume and average cartilage thick-
ness showed a weak but statistically signiﬁcant negative
correlation with the pain scores and the three dimensions
of the WOMAC in the lateral tibia plateau in OA patients
(volume: 11-PT NRS: r¼0.388, P¼ 0.034; VAS: r¼
0.406, P¼ 0.026; WOMAC pain: r¼0.419, P¼ 0.021;
WOMAC stiffness: r¼0.418, P¼ 0.007; average thick-
ness: 11-PT NRS: r¼0.393, P¼ 0.032; VAS: 0.420,
P¼ 0.021; WOMAC pain: r¼0.383, P¼ 0.037; WOMAC
stiffness: r¼0.492, P¼ 0.006).
In the medial tibia plateau, changes in cartilage
volume and average cartilage thickness were positively
correlated with changes in JSW (volume: r¼ 0.747,
P¼ 0.002; average thickness: r¼ 0.566, P¼ 0.035) in
OA patients.
Discussion
In our study, we sought to monitor MRI-derived measure-
ments of knee cartilage morphometry and biochemical
composition in subjects with a potentially more progressive
course of OA. Given the inclusion criteria these patients
also were more likely to have changes in collagen integrity
and/or cartilage volume as previously described35. We
also examined healthy controls to determine the rate of
change for subjects with the same gender and similar
age36,37 as a reference. In order to assess short-time vari-
ations we chose an observation period of 1 year with a total
of four surveys including 3-, 6- and 12-month follow-up
examinations.
OA patients presented with signiﬁcantly higher T2 relax-
ation times than the controls. This is in agreement with
previous ﬁndings in human subjects21,23, in in vitro human
specimen studies22,24 and in OA animal models13,38.
T2 relaxation time of the cartilage is a parameter which
is inﬂuenced by several factors: the orientation of the
collagen ﬁbers to the static magnetic ﬁeld (‘magic angle
effect’39), the amount of water content14,36, alterations in
water proton mobility36 and the integrity of the collagenous
structures in the extracellular cartilage matrix40,41. Since
OA is characterized by hydration of the cartilage and
collagen breakdown, our results are consistent with these
ﬁndings.
We would have expected an increase in T2 relaxation
times in our cohort of OA patients during the follow-up pe-
riod. Instead we observed no signiﬁcant change, yet a trend
to decreased T2 relaxation time in both subject groups in 1
year. Blumenkrantz et al.21 demonstrated an increase of T2
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Average thickness of cartilage [mm] and its change over the 1-year follow-up. Intergroup comparison of the absolute values1) and of the
slope2) was performed with mixed model analysis after adjusting for age, height, weight and time point of examination. P-values in bold
indicate significant group differences. Lateral compartment3) consists of lateral femur condyle and lateral tibia plateau. Medial compartment4)
consists of medial femur condyle and medial tibia plateau
BL (meanSD) 12 Months (meanSD) Change from BL (meanSE)
Patients Controls Patients Controls P-values1) Patients Controls P-values2)
Femur (total) 1.46 0.29 1.40 0.20 1.49 0.17 1.41 0.22 0.265 0.03 0.03 0.02 0.03 0.256
Lateral condyle (weight-bearing) 1.07 0.98 1.18 0.21 1.40 0.35 1.00 0.77 0.109 0.18 0.30 0.22 0.25 0.308
Lateral condyle (non-weight-bearing) 1.45 0.25 0.91 0.70 1.06 0.98 1.11 0.31 0.686 0.35 0.23 0.19 0.19 0.085
Medial condyle (weight-bearing) 0.60 1.13 1.05 0.34 0.74 0.72 0.99 0.28 0.278 0.12 0.21 0.04 0.17 0.542
Medial condyle (non-weight-bearing) 1.54 0.39 1.32 0.42 1.34 0.31 1.27 0.44 0.539 0.11 0.10 0.06 0.08 0.682
Trochlea 1.48 0.29 1.50 0.21 1.51 0.21 1.50 0.21 0.528 0.01 0.04 0.00 0.03 0.758
Tibia (total) 1.59 0.23 1.90 0.29 1.68 0.31 1.91 0.34 0.005 0.12 0.05 0.00 0.04 0.083
Lateral plateau 1.91 0.48 2.16 0.40 1.96 0.59 2.17 0.43 0.038 0.13 0.06 0.01 0.05 0.120
Medial plateau 1.23 0.34 1.56 0.18 1.38 0.25 1.56 0.26 0.006 0.11 0.07 0.01 0.06 0.184
Lateral compartment3) 1.52 0.35 1.49 0.20 1.55 0.29 1.51 0.22 0.701 0.01 0.03 0.03 0.03 0.673
Medial compartment4) 1.36 0.24 1.40 0.23 1.42 0.20 1.40 0.27 0.242 0.00 0.06 0.00 0.05 0.949
All 1.47 0.24 1.46 0.18 1.50 0.18 1.46 0.21 0.827 0.01 0.03 0.01 0.03 0.676relaxation time in mild OA subjects after a longer observa-
tion interval of 2-year follow-up. In our 1-year study, also
the minimal JSW and clinical assessment scores did not
change over time. Furthermore, the T2 relaxation times
were not correlated with these indicators of progressing
OA. We therefore conclude that the bulk T2 relaxation
time and the clinical surrogate markers for progress of the
disease may not be sensitive enough to monitor changes
within a short-term follow-up period of 12 months. Studies
from Mosher et al.42 and Nissi et al.41 suggested that an in-
crease of T2 times due to senescent and degenerative car-
tilage collagen changes may start in the superﬁcial zone of
the cartilage before they comprise the entire cartilage thick-
ness. Future work therefore, will have to focus on the eval-
uation of the superﬁcial layer of the cartilage in order to
potentially detect early changes in the status of the disease
more sensitively.
The OA patients in this study had signiﬁcantly lower car-
tilage volume and average cartilage thickness in both tibia
plateaus compared to controls whereas in the femoral car-
tilage no differences in these parameters were observed.
Several studies have demonstrated that MRI of the knee
cartilage is a speciﬁc and sensitive way of quantifying carti-
lage loss7,8,11,12,33,43e48. Since our patients were included
in the study after having a radiographic conﬁrmation of
OA diagnosis (KL score 2e3), it could be assumed that
the disease preexisted for some time and a cartilage vol-
ume loss had already occurred.
Regarding the amount of change in cartilage volume
we observed an increase of 3% in our patients in the tibia
during the follow-up. This is in contrast to the studies ref-
erenced above: those authors report a calculated average
amount of cartilage loss from 0.4% to 8.6% each year
with an average range from 3% to 5%. In our OA popu-
lation, two patients could be identiﬁed that contributed
substantially to the perceived increase in cartilage volume
as shown in Fig. 6. Carefully reevaluating the ﬁrst patient,
who had an increase in cartilage volume of 22.8%, we
found a history of increased physical activity after our di-
agnosis of OA and additional chondroitin sulfate medica-
tion. Roos and Dahlberg49 demonstrated that subjects at
high risk of knee OA who begin exercising at regular
intervals showed an increase of glycosaminoglycanscontent in knee cartilage. It is therefore possible that
the observed gain in cartilage volume in this patient
corresponds to an adaptation in loading change of the
joint. The second patient did not reveal any special ﬁnd-
ings in her medical history. Both the patients did not
show a T2 relaxation time pattern which would indicate
a volume increase due to cartilage edema and swelling.
Assuming that these increases of cartilage volume are
not typical during the course of OA and excluding these
patients from our statistical analysis no signiﬁcant change
of cartilage volume over the 12 months period was found.
The expected decrease may be seen in subsequent
follow-up as this effect may initially be sometimes
hardly noticeable. For example, Gandy et al.47 could not
demonstrate a volume change in any of the knee carti-
lage compartments after 1 year in a population of 16
patients and a decrease of 1.6% occurred after an obser-
vation period of 3 years. Also the small sample size of
our study may account for the lack of this effect within
1 year.
At BL we found strong positive correlations of T2 relax-
ation times with femoral cartilage volume and average car-
tilage thickness in the OA patients, which decreased
during the follow-up. We hypothesize that these correla-
tions likely reﬂect the stage of cartilage swelling which oc-
curs in the initial phase of the disease5 and leads to
increased water content as well as an enlargement of
the cartilage volume.
Even though we did not ﬁnd a distinct progression of OA
in our study, we demonstrated some weak signiﬁcant corre-
lations between the change of clinical pain scores and the
minimal JSW with the change of cartilage morphometric in-
dices in the tibia of the patients. On the other side, no cor-
relations between the change of clinical parameters of OA
and the change of T2 relaxation times were found. Since
the tibia is the most affected compartment in our cohort
we conclude that MRI-derived cartilage morphometry is
possibly a more sensitive parameter than the estimation
of T2 relaxation times for indicating changes in the status
of early OA.
A limitation of our study is the small sample size of
patients and controls. However, these subjects were thor-
oughly monitored at short-time intervals. Careful
1232 R. Stahl et al.: Knee OA: cartilage T2 and volume changesimultaneous assessment of accepted clinical and radio-
graphic progress indicators of OA was also performed.
In conclusion, we have shown that T2 relaxation times
are signiﬁcantly higher in the tibio-femoral cartilage of
patients with early knee OA compared to healthy controls,
allowing differentiation of patients with and without dis-
ease. However, the amount of T2 relaxation times did
not change within 1 year during the course of the disease
as well as in comparison to the control group. Similar re-
sults were found for MRI-derived cartilage morphometry
as well as radiographically determined JSW and clinical
pain scores. This suggests that with smaller sample sizes
these parameters may be of limited value to monitor pro-
gression of disease during a short-term follow-up period of
12 months.
Fig. 5. Average thickness of the cartilage in the lateral (a), medial
(b) and whole tibial (c) compartments. OA patients had signiﬁcantly
lower values than the controls. The average thickness showed
a trend to increase over time in the patient group. However, this
was not statistically signiﬁcant (P> 0.05).Acknowledgements
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